Yossef, S., Clark, F., Bubeck, S. S., Abernethy, J., Bayne, T., Krishnan, K., & Young, A. (2020). An Oral Formulation of the Probiotic, Bacillus subtilis HU58, Was Safe and Well Tolerated in a Pilot Study of Patients with Hepatic Encephalopathy. Evid Based Complement Alternat Med.

Yossef, Sayed, Frances Clark, Sarah S. Bubeck, John Abernethy, Thomas Bayne, Kiran Krishnan, i Aicacia Young. "An Oral Formulation of the Probiotic, Bacillus Subtilis HU58, Was Safe and Well Tolerated in a Pilot Study of Patients With Hepatic Encephalopathy." Evid Based Complement Alternat Med 2020.

Yossef, Sayed, et al. "An Oral Formulation of the Probiotic, Bacillus Subtilis HU58, Was Safe and Well Tolerated in a Pilot Study of Patients With Hepatic Encephalopathy." Evid Based Complement Alternat Med 2020.